Process to prepare sulfonyl chloride derivatives

Details for Australian Patent Application No. 2007225476 (hide)

Owner AstraZeneca AB

Inventors Horner, Daniel; Cornwall, Philip

Agent Freehills

Pub. Number AU-A-2007225476

PCT Pub. Number WO2007/106021

Priority 60/782,892 16.03.06 US

Filing date 15 March 2007

Wipo publication date 20 September 2007

International Classifications

C07D 233/76 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/106021 Priority application(s): WO2007/106021

23 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007225477-A new crystalline form G of (5S) -5- [4- (5-chloro-pyridin-2yloxy) - piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (I) and intermediates thereof.

2007225471-Bezothiazol derivatives as beta2 adrenoreceptor agonists